A. A. Ziatskov

A. A. Ziatskov

Auto-generated profile, based on publicly available information

A. A. Ziatskov

Gomel State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Health and Ecology Issues
Verified
Journal Article
Open access
PDF file
NBN. A. Bonda
N. A. Bonda
ISIgor Stoma
Igor Stoma
OOO. V. Osipkina
O. V. Osipkina
AZA. A. Ziatskov
A. A. Ziatskov
ASA. S. Shaforost
A. S. Shaforost
ДТД. В. Тапальский
Д. В. Тапальский
Objective. To evaluate genetic mechanisms of antibiotic resistance and virulence of invasive strains of Klebsiella pneumoniae isolated from inpatients using whole genome sequencing.Materials and methods. For two carbapenem-resistant multiple-antibiotic-resistant invasive strains of K.pneumoniae, as well as two carbapenem-sensitive invasive strains of K.pneumoniae, sequencing was performed using the MiSeq genomic sequencer (Illumina). Genomic sequences were assembled and annotated. Sequence type determination, search for plasmids and virulence factors, antibiotic resistance genes, and efflux mechanisms were performed.Results. K.pneumoniae strains belonged to sequence types ST395, ST101, ST111, and ST512 s and had a hypermucoid phenotype. The iutA aerobactin genes were detected in both sensitive and carbapenem-resistant strains. Virulence genes fimH, fyuA, and irp2 were detected in one strain isolated from blood. Carbapenemase genes (blaKPC, blaNDM) were detected in two strains. Aminoglycosides and fluoroquinolones resistance genes were detected in 3 of 4 strains. All strains showed the presence of different systems of active antibiotic elimination from the microbial cell.Conclusion. The possibility of identifying hypervirulent strains of K.pneumoniae using a complex phenotypic test along with hvKp genotyping is shown. The results of full-genome sequencing reflect significant resistance of hypervirulent K.pneumoniae strains isolated from blood to most antibiotics, including β-lactams, aminoglycosides, fluoroquinolones, phosphomycin, chloramphenicol and polymyxins.

30 March 2022 in Health and Ecology Issues
Verified
Journal Article
Open access
PDF file
ALA. A. Lyzikov
A. A. Lyzikov
ДТД. В. Тапальский
Д. В. Тапальский
YDY. Y. Doroshko
Y. Y. Doroshko
ETE. A. Tsvetkova
E. A. Tsvetkova
AZA. A. Ziatskov
A. A. Ziatskov
ЕДЕ. Ю. Дорошко
Е. Ю. Дорошко
Objective. To optimize the composition of polymer coatings based on the assessment of the duration of the antibacterial resistance in infected wounds of laboratory animals.Materials and methods. Woven vascular prostheses consisting of fibrous-porous polypropylene and one of the three types of coatings based on a polyvinyl-chitosan complex with the addition of biologically active substances were used in the study. All the samples were impregnated with 1% vancomycin for 30 minutes. The research methods were: bacteriological, molecular and genetic methods. Qualitative results of the antibacterial resistance of the coatings during the study period in the groups were confirmed with three or more repetitions of the results.Results. In the qualitative assessment of the duration of the antibacterial resistance of the prostheses according to the PCR and bacteriological studies, woven vascular prostheses with coatings containing polyvinyl alcohol, polyvinylpyrrolidone, chitosan, antibiotic vancomycin, and hyaluronic acid do not get infected with S. aureus for up to four days, and woven vascular prostheses with coatings consisting of polyvinyl alcohol, polyvinylpyrrolidone, chitosan, antibiotic vancomycin, and L-aspartic acid and woven prostheses with coatings of polyvinyl alcohol, chitosan, antibiotic vancomycin, and L–aspartic acid up to five days.Conclusion. The presence of L-aspartic acid in the composition of polymer coatings increases the duration of the antibacterial resistance of woven vascular prostheses in comparison with hyaluronic acid. The presence of polyvinylpyrrolidone in polymer coatings significantly (p = 0.012) reduces the contamination of S. aureus, increasing the antibacterial resistance of woven vascular prostheses, whereas polyvinyl alcohol does not have such an effect.

29 March 2025 in Health and Ecology Issues
Verified
Journal Article
Open access
PDF file
ASA. S. Starovoitova
A. S. Starovoitova
ISIgor Stoma
Igor Stoma
AUA. A. Ulezko
A. A. Ulezko
EVE. V. Voropaev
E. V. Voropaev
OOO. V. Osipkina
O. V. Osipkina
AKA. A. Kovalev
A. A. Kovalev
Objective. To establish the composition of microbiome and select target taxa of upper respiratory tract biomaterial in order to apply the results in the model of diagnosis of Congenital pneumonia (ICD – 10 P23), based on a microbiome-associated approach to providing medical care to premature newborns.Materials and methods. The study group consisted of 154 premature newborns. The sampling was carried out in the first 5-15 minutes of life with a sterile probe swab. The composition of the upper respiratory tract microbiota in newborns was determined by the new generation sequencing method. Statistical data processing was carried out in the R programming environment (version4.3.1), the RStudio program (2023.09.1+494). The significance level is assumed to be 0.05.Results. According to the sequencing results, the genera Brucella (≥5.8%), Achromobacter (≥3.1%), Ralstonia (≥0.3%), Stenotrophomonas (≥9.0%), Klebsiella (≥0.02%), Pseudomonas (≥1.5%) in children with chronic intrauterine hypoxia were proposed to be used in the model of diagnosis of “Congenital pneumonia” (ICD – 10 P23) as a part of microbiome-associated approach to providing medical care to premature newborns. A combination (Pseudomonas + Klebsiella) has been isolated molecularly and genetically, which is significantly predominant in the group of premature newborns with a verified diagnosis of Congenital pneumonia.Conclusion. Development of a microbiome-associated approach to providing medical care to premature newborns with congenital pneumonia will reduce the time spent on diagnostic search, and allow conduct therapy that meets the principles of personalized medicine.

28 December 2020 in Health and Ecology Issues
Verified
Journal Article
Open access
PDF file
ASA. G. Skuratov
A. G. Skuratov
ASA. S. Shaforost
A. S. Shaforost
AZA. A. Zyatskov
A. A. Zyatskov
ALA. N. Lyzikov
A. N. Lyzikov
OOO. V. Osipkina
O. V. Osipkina
EVE. V. Voropaev
E. V. Voropaev
Objective: to test and optimize a method for detecting clustered DNA lesions with an assessment of the quantitative characteristics of hepatic changes using an experimental model of acute toxic hepatitis.Material and methods: Laboratory C57Bl/6 mice at the age of 10 weeks were used for the study. Acute toxic liver injury was induced by means of a single intraperitoneal injection of 30 % CCI4 solution in olive oil. The withdrawal of the animals from the experiment was made after 72 hours. For the detection of clustered DNA lesions, a liver fragment was resected.Results. The electrophoretic parameters which are the most optimal for obtaining primary data for the subsequent calculation of the number of clustered DNA lesions have been proposed. The number of clusters in the DNA samples from the animals of the control group is significantly lower than in the experimental group and amounts to 54.80 [37.65; 59.24] and 76.82 [60.95; 92.41] APE1 clusters per million bp., respectively.Conclusion. Successful testing and optimization of the OCDL method for the detection of clustered lesions in liver DNA have been performed. The study has shown an increase in the number of APE1 clusters and double-strand breaks in the DNA of the C57Bl laboratory mice with induced acute toxic hepatitis, which indicates significant derangement of DNA integrity and a high risk of developing progressive liver diseases in its toxic damage.

14 January 2025 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
ISIgor Stoma
Igor Stoma
EVE. V. Voropaev
E. V. Voropaev
EME. I. Mikhailova
E. I. Mikhailova
KKK. S. Korsak
K. S. Korsak
OOO. V. Osipkina
O. V. Osipkina
AHA. Ev. Hancharou
A. Ev. Hancharou
Relevance. The development and production of own vaccine contributes to the growth of professional competencies of the scientific community, improvement and modernization of the country's industrial production.Aims. To evaluate the immunogenicity parameters of whole-virion vaccine against SARS-CoV-2 in a phase I, II clinical trial (up to day 180).Materials & Methods. The clinical study included a phase I/II trial. In Phase I, a sequential allocation of subjects (1:1) by open-label method into two groups with a single administration of vaccine at dose 1 and at dose 2 was performed. In phase II (double-blind randomized), subjects were allocated to immunization with vaccine at doses 1, 2 or placebo in a 1:1:1 ratio. To evaluate the immunogenicity of an inactivated whole-virion booster vaccine against SARS-CoV-2 («BelCovidVac») in 135 healthy subjects (18–50 years of age in phase 1 and 18-60 years of age in phase 2) previously vaccinated/recovered from COVID-19. IgG concentration (BAU/mL) to the S-protein of SARS-CoV-2 was measured by the «SARS-CoV-2-IgG quantitative-ELISA-BEST» ELISA kit, viral neutralising activity of sera and proliferative activity of T-lymphocytes were evaluated, geometric mean (GMC) of IgG concentration was calculated, geometric mean of virus neutralizing activity titer (GMT compared to baseline. Statistical processing of the data was performed using the R programming language.Results. The values of fold change in IgG concentration to SARS-CoV-2 on day 42 and 90 in subjects who received «BelCovidVac» vaccine were significantly higher than those of subjects who received placebo (p=0,05, p=0,02, respectively). The value of the fold change in the titer of viral neutralizing activity in the study subjects who received «BelCovidVac» vaccine was significantly higher than the values of the subjects who received placebo (p=0,02). A statistically significant positive correlation (ρSp=0,51 p=0,0005) between the content of antigen-specific T-cells and the level of IgG after 28 days in the studied subjects and between the fold change in the titer of viral neutralizing activity of sera and the fold change in IgG concentration (ρSp = 0,40 p<0,001) was established. On day 180, all groups of subjects show a decrease in antigen-specific IgG concentrations to the initial level.Discussion. At the time of the search for volunteers and the beginning of the clinical trial of the vaccine «BelKovidVac» the immune layer of the population had already been formed, which made the task of the researchers more difficult. But the vaccine «BelKovidVac» showed its immunogenicity, as evidenced by the results of the study.Conclusions. A significant increase in GMC IgG and GMT viral neutralizing activity of sera in the group vaccinated with «BelCovidVac» and no significant increase in GMC IgG and GMT viral neutralizing activity of sera in the placebo group were revealed, which is the evidence of immune response stimulation as a result of «BelCovidVac» vaccine administration and its efficacy.

16 January 2025 in Health and Ecology Issues
Verified
Journal Article
Open access
PDF file
EVE. V. Voropaev
E. V. Voropaev
OOO. V. Osipkina
O. V. Osipkina
AKA. A. Kovalev
A. A. Kovalev
ASA. S. Shaforost
A. S. Shaforost
AZA. A. Ziatskov
A. A. Ziatskov
ISIgor Stoma
Igor Stoma
Objective. To evaluate dynamic changes in the gastric microbiota against the background of Helicobacter pylori eradication therapy in a patient with gastritis using the method of high-throughput sequencing based on the analysis of variable regions of the 16s rRNA gene.Materials and methods. The patient (male, 57 years old) with chronic associated Helicobacter pylori (H. pylori) moderately severe and moderately active gastritis of the antrum and body of the stomach without atrophy and metaplasia. There is no primary resistance of H. pylori to clarithromycin according to polymerase chain reaction results.Next generation sequencing method based on the analysis of variable regions of the 16S rRNA gene was used to study the gastric microbiota. H. pylori eradication was performed according to the following scheme: amoxicillin, clarithromycin, omeprazole. The study included gastric mucosa (GM) biopsy samples obtained from unchanged tissue (N) and pathologically altered tissue (P) at different stages of treatment during 12 months. Taxonomic identification of reads was performed using the DRAGEN Metagenomics software package (Kraken2 algorithm).Results. Negative dynamics of alpha-diversity of gastric microbiome (by 5.8 times) was noted in the patient without treatment when assessing the unchanged tissue of the stomach. When antibiotic therapy was used, an increase in alpha-diversity of the gastric microbiota by more than eight times was noted.Conclusion. Analysis of the data of taxonomic diversity of gastric microbiota in morphologically different samples of the gastric microbiota at different stages of therapy indicates positive changes in the dynamic composition of the gastric microbiota in the course of treatment, which is confirmed by a decrease in the relative representation of H. pylori. When using therapy based only on proton pump inhibitors, the number of H. pylori is not significantly reduced. The dynamics of alpha-diversity of gastric microbiota is related to the morphological state of the tissue, and without the use of therapy has a significant and rather rapid tendency to a significant decrease (2-fold in less than two months). It is possible to achieve reduction of H. pylori to minimal amounts using standard first-line eradication therapy based on clarithromycin, but complete eradication does not occur.